Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson's substantia nigra
Scott Ayton, Peng Lei, Catriona Mclean, Ashley Bush, David Finkelstein
SIGNAL TRANSDUCTION AND TARGETED THERAPY | NATURE PUBLISHING GROUP | Published : 2016
Related Projects (2)
Awarded by Australian National Health & Medical Research Council
This work was supported by funds from the Australian Research Council, the Australian National Health & Medical Research Council (GNT1100441 and GNT1044542), the CRC for Mental Health and Operational Infrastructure Support Victorian State Government. The Victorian Brain Bank Network is supported by The University of Melbourne, The Mental Health Research Institute, The Alfred Hospital and the Victorian Forensic Institute of Medicine, and funded by Neurosciences Australia and the National Health and Medical Research Council.